John Lunger, Chief Patient Supply Officer: Adaptimmune Therapeutics ADAPY Sell · Filed 24/01/17

Trade details

Type: Insider sale
Amount: $8,579.35
Shares · price: 12,805 sh · $0.67 a share
Held after: 19,015 sh
Stock: Adaptimmune Therapeutics ADAPY
Person: John LungerChief Patient Supply Officer
Trade date: 24/01/17
Filed: 24/01/17
Days to filing: 0 days

Sold 40.2% of holdings

Share of holding sold: 40.2%

Adaptimmune Therapeutics trades, last 26 weeks

What else happened in Adaptimmune Therapeutics around then

Filed or reported within 30 days of the trade day · 23/12/18~24/02/16

John Lunger's recent trades

John LungerChief Patient Supply Officer
SellAdaptimmune Therapeutics
Sell
Adaptimmune Therapeutics
ADAPY
$3,239
5,584 sh
$3,239
Filed 25/01/17
Traded 25/01/17
John LungerChief Patient Supply Officer
Planned saleAdaptimmune Therapeutics
Planned sale
Adaptimmune Therapeutics
ADAPY
$3,243
5,584 sh
$3,243
Filed 25/01/17
Traded 25/01/17
John LungerChief Patient Supply Officer
SellAdaptimmune Therapeutics
Sell
Adaptimmune Therapeutics
ADAPY
$5,588
9,803 sh
$5,588
Filed 25/01/15
Traded 25/01/15
John LungerChief Patient Supply Officer
SellAdaptimmune Therapeutics
Sell
Adaptimmune Therapeutics
ADAPY
$3,228
5,471 sh
$3,228
Filed 25/01/15
Traded 25/01/13
John LungerChief Patient Supply Officer
SellAdaptimmune Therapeutics
Sell
Adaptimmune Therapeutics
ADAPY
$2,518
4,268 sh
$2,518
Filed 25/01/15
Traded 25/01/13